What's new

Summary of opinion: Enhertu, 27/02/2025 Positive

Summary of opinion: Enhertu, 27/02/2025 Positive

Feb 28, 2025 - 13:44
 0
Summary of opinion: Enhertu, 27/02/2025 Positive
Summary of opinion: Enhertu, 27/02/2025 Positive
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Lynozyfic, linvoseltam...

Next Article

Summary of opinion: Prevymis, 27/02/2025 Positive

Related Posts

Human medicines European public assessment report (EPAR): Opfolda, miglustat, Date of authorisation: 26/06/2023, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 14, 2025  0

Product Management Service (PMS) webinar on Product User Interface (PUI) edit functionalities for industry users, Online, from 28 January 2025, 10:00 (CET) to 28 January 2025, 12:00 (CET)

Product Management Service (PMS) webinar on Product Use...

Feb 9, 2025  0

QRD veterinary product-information highlighted template...

Feb 14, 2025  0